LTFS
ALNY icon

Ladenburg Thalmann Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$73K Sell
754
-1,213
-62% -$121K ﹤0.01% 3253
2019
Q3 		$158K Buy
1,967
+1,130
+135% +$89.4K ﹤0.01% 2633
2019
Q2 		$61K Buy
837
+434
+108% +$33.3K ﹤0.01% 3319
2019
Q1 		$37K Hold
403
– – ﹤0.01% 3604
2018
Q4 		$29K Buy
403
+103
+34% +$7.92K ﹤0.01% 3639
2018
Q3 		$27K Buy
+300
New +$30.2K ﹤0.01% 3703
2018
Q1 		– Sell
-225
Closed -$29K – 5095
2017
Q4 		$29K Sell
225
-326
-59% -$41K ﹤0.01% 3561
2017
Q3 		$65K Sell
551
-35
-6% -$2.99K ﹤0.01% 2908
2017
Q2 		$47K Buy
586
+225
+62% +$14.4K ﹤0.01% 3066
2017
Q1 		$18K Sell
361
-515
-59% -$23.8K ﹤0.01% 3613
2016
Q4 		$33K Sell
876
-219
-20% -$9.17K ﹤0.01% 3138
2016
Q3 		$75K Sell
1,095
-2,399
-69% -$169K ﹤0.01% 2456
2016
Q2 		$194K Buy
3,494
+2,853
+445% +$180K ﹤0.01% 1702
2016
Q1 		$41K Buy
641
+215
+50% +$14.3K ﹤0.01% 2733
2015
Q4 		$40K Buy
426
+100
+31% +$9.27K ﹤0.01% 2726
2015
Q3 		$26K Sell
326
-27
-8% -$3K ﹤0.01% 2922
2015
Q2 		$42K Sell
353
-53
-13% -$6.33K ﹤0.01% 2702
2015
Q1 		$42K Sell
406
-133
-25% -$13.5K ﹤0.01% 2680
2014
Q4 		$52K Buy
539
+239
+80% +$22.1K ﹤0.01% 2335
2014
Q3 		$23K Hold
300
– – ﹤0.01% 2530
2014
Q2 		$19K Hold
300
– – ﹤0.01% 2694
2014
Q1 		$20K Sell
300
-100
-25% -$7.74K ﹤0.01% 2563
2013
Q4 		$26K Hold
400
– – ﹤0.01% 2358
2013
Q3 		$26K Sell
400
-900
-69% -$44.9K ﹤0.01% 2262
2013
Q2 		$40K Buy
+1,300
New +$34.6K ﹤0.01% 1870

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ALNY Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Alnylam Pharmaceuticals (ALNY) stake by 62% in Q4 2019, selling an estimated $121K and leaving 754 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #3253.

Ladenburg Thalmann Financial Services first reported a position in ALNY in Q2 2013 and has held it in 25 quarters since. The position peaked at $194K in Q2 2016. 316 funds tracked by Wall St. Rank hold ALNY as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 754 shares of Alnylam Pharmaceuticals worth $73K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 1,213 Alnylam Pharmaceuticals shares in Q4 2019, an estimated $121K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3253 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 25 quarters since.
  • Ladenburg Thalmann Financial Services's Alnylam Pharmaceuticals position peaked at $194K in Q2 2016.
  • 316 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.